Seven in ten Brits believe today's children use fewer words than previous generations, with 67% saying kids now struggle to ...

THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27, ...

Lexicon Inc., a Little Rock-based construction management and steel fabrication company, said Thursday it has become a private, employee-owned company.

Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.

The company also stands to gain from recent regulatory FDA guidance aimed at streamlining the development of non-opioid ...

Our End-of-Phase 2 meeting with FDA was productive and provided Lexicon with the insights needed to design a robust Phase 3 program, with the goal of making the first non-opioid DPNP medicine ...

Cannabis aroma quality is primarily determined by aroma, not THC potency, challenging traditional assumptions. GC-MS and GC-PFPD analyses reveal that terpenes alone do not predict sensory perception, ...

Lexicon has announced the addition of James “Jamie” Williams as its new manager of training and development, bringing decades of leadership and instructional expertise to the Arkansas-based company.

Lexicon Pharmaceuticals (NASDAQ:LXRX) is one of the fastest-growing penny stocks to buy now. On November 18 at the Jefferies London Healthcare Conference 2025, Lexicon Pharmaceuticals (NASDAQ:LXRX) ...

Lexicon Inc., Little Rock, Ark., has hired Catherine Brumbaugh as director of training and development. She has more than 20 years of experience in talent management, leadership development, and ...

Lexicon, Inc. has named Catherine Brumbaugh as director of training and development, tasking her with advancing leadership, skills training, and employee engagement across its companies. LITTLE ROCK – ...